Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian Cancer (TRIAS 2009)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2011 by Charite University, Berlin, Germany.
Recruitment status was  Recruiting
Study NCT01047891   Information provided by Charite University, Berlin, Germany

First Received on January 12, 2010.   Last Updated on February 10, 2011   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial